Immunogen Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
35,535.00
59,896.00
85,541.00
43,012.00
115,447.00
53,446
Cost of Goods Sold (COGS) incl. D&A
-
-
-
6,148.00
-
-
Gross Income
-
-
-
36,864.00
-
-
SG&A Expense
103,903.00
126,829.00
134,483.00
162,974.00
167,687.00
203,791
EBIT
73,009.00
71,531.00
54,455.00
126,110.00
58,203.00
157,756
Unusual Expense
197.00
2.00
-
4,431.00
23,694.00
3,693
Non Operating Income/Expense
1.00
121.00
916.00
5,915.00
1,461.00
895
Interest Expense
-
-
5,437.00
21,828.00
16,722.00
10,726
Pretax Income
72,811.00
71,364.00
60,739.00
157,766.00
96,012.00
168,843
Consolidated Net Income
72,811.00
71,364.00
60,739.00
157,766.00
96,012.00
168,843
Net Income
72,811.00
71,364.00
60,739.00
157,766.00
96,012.00
168,843
Net Income After Extraordinaries
72,811.00
71,364.00
60,739.00
157,766.00
96,012.00
168,843
Net Income Available to Common
72,811.00
71,364.00
60,739.00
157,766.00
96,012.00
168,843
EPS (Basic)
0.87
0.83
0.71
1.81
0.98
1.21
Basic Shares Outstanding
84,063.00
85,481.00
86,038.00
87,102.00
98,068.00
139,946
EPS (Diluted)
0.87
0.83
0.71
0.91
0.98
1.21
Diluted Shares Outstanding
84,063.00
85,481.00
86,038.00
87,102.00
98,068.00
139,946
EBITDA
68,368.00
66,933.00
48,942.00
119,962.00
52,240.00
150,345
Non-Operating Interest Income
-
44.00
69.00
518.00
1,146.00
4,227
About Immunogen
View Profile
